PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CORT vs. AMPH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between CORT and AMPH is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

CORT vs. AMPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corcept Therapeutics Incorporated (CORT) and Amphastar Pharmaceuticals, Inc. (AMPH). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%100.00%JulyAugustSeptemberOctoberNovemberDecember
78.30%
-0.83%
CORT
AMPH

Key characteristics

Sharpe Ratio

CORT:

1.31

AMPH:

-0.81

Sortino Ratio

CORT:

1.80

AMPH:

-1.03

Omega Ratio

CORT:

1.27

AMPH:

0.87

Calmar Ratio

CORT:

1.91

AMPH:

-0.74

Martin Ratio

CORT:

4.00

AMPH:

-1.12

Ulcer Index

CORT:

17.92%

AMPH:

28.53%

Daily Std Dev

CORT:

54.64%

AMPH:

39.34%

Max Drawdown

CORT:

-94.28%

AMPH:

-49.92%

Current Drawdown

CORT:

-13.85%

AMPH:

-39.31%

Fundamentals

Market Cap

CORT:

$5.78B

AMPH:

$1.96B

EPS

CORT:

$1.26

AMPH:

$3.01

PE Ratio

CORT:

43.76

AMPH:

13.57

PEG Ratio

CORT:

0.61

AMPH:

2.77

Total Revenue (TTM)

CORT:

$628.56M

AMPH:

$721.15M

Gross Profit (TTM)

CORT:

$618.75M

AMPH:

$374.85M

EBITDA (TTM)

CORT:

$144.05M

AMPH:

$267.92M

Returns By Period

In the year-to-date period, CORT achieves a 61.39% return, which is significantly higher than AMPH's -36.22% return. Over the past 10 years, CORT has outperformed AMPH with an annualized return of 32.50%, while AMPH has yielded a comparatively lower 12.63% annualized return.


CORT

YTD

61.39%

1M

-0.38%

6M

86.22%

1Y

67.85%

5Y*

33.11%

10Y*

32.50%

AMPH

YTD

-36.22%

1M

-10.67%

6M

-1.50%

1Y

-34.75%

5Y*

15.04%

10Y*

12.63%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CORT vs. AMPH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Amphastar Pharmaceuticals, Inc. (AMPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CORT, currently valued at 1.31, compared to the broader market-4.00-2.000.002.001.31-0.81
The chart of Sortino ratio for CORT, currently valued at 1.80, compared to the broader market-4.00-2.000.002.004.001.80-1.03
The chart of Omega ratio for CORT, currently valued at 1.27, compared to the broader market0.501.001.502.001.270.87
The chart of Calmar ratio for CORT, currently valued at 1.91, compared to the broader market0.002.004.006.001.91-0.74
The chart of Martin ratio for CORT, currently valued at 4.00, compared to the broader market0.0010.0020.004.00-1.12
CORT
AMPH

The current CORT Sharpe Ratio is 1.31, which is higher than the AMPH Sharpe Ratio of -0.81. The chart below compares the historical Sharpe Ratios of CORT and AMPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
1.31
-0.81
CORT
AMPH

Dividends

CORT vs. AMPH - Dividend Comparison

Neither CORT nor AMPH has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CORT vs. AMPH - Drawdown Comparison

The maximum CORT drawdown since its inception was -94.28%, which is greater than AMPH's maximum drawdown of -49.92%. Use the drawdown chart below to compare losses from any high point for CORT and AMPH. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-13.85%
-39.31%
CORT
AMPH

Volatility

CORT vs. AMPH - Volatility Comparison

Corcept Therapeutics Incorporated (CORT) has a higher volatility of 12.22% compared to Amphastar Pharmaceuticals, Inc. (AMPH) at 9.03%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than AMPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
12.22%
9.03%
CORT
AMPH

Financials

CORT vs. AMPH - Financials Comparison

This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Amphastar Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab